RayKnowChina Research Map
Shortlist

Guangdong Pharmaceutical University

广东药科大学

GuangzhouUniversity or health system

Hospitals that carry this university's name, added together, plus papers and trials that name only the university.

Research activity, not treatment quality. Not medical advice. How this works

Nasopharyngeal carcinoma

鼻咽癌
0.2%Leads under 1 in 100 of China's research papers on NPC

Led 4 of 2,375 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (23.4%).

Run this PubMed search

Open trials led
0
Research papers it led
4
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.1%
Papers led per year
2021: 0020212022: 2220222023: 2220232024: 0020242025: 002025
ThemesRecurrent / metastatic diseaseEBV & screeningImmunotherapy

Hospitals counted here

  1. First Affiliated Hospital of Guangdong Pharmaceutical University4

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Hepatocellular carcinoma

肝细胞癌
0.1%Leads under 1 in 100 of China's research papers on HCC

Led 16 of 14,765 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (5.5%).

Run this PubMed search

Open trials led
0
Research papers it led
16
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.06%
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 1120242025: 442025
ThemesImaging, AI & early detectionImmunotherapy & targeted drugsHepatitis B & cirrhosis

Over half of these papers are lab or animal studies.

Hospitals counted here

  1. First Affiliated Hospital of Guangdong Pharmaceutical University Counted in the group total6

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Stomach cancer

胃癌
0.06%Leads under 1 in 100 of China's research papers on Stomach cancer

Led 6 of 9,782 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (3.9%).

Run this PubMed search

Open trials led
0
Research papers it led
6
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.03%
Papers led per year
2021: 1120212022: 1120222023: 1120232024: 0020242025: 112025
ThemesImaging & AIEarly detection & endoscopy

Hospitals counted here

  1. First Affiliated Hospital of Guangdong Pharmaceutical University Counted in the group total2
  2. Guangzhou Fosun Chancheng Hospital1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Neuroblastoma

神经母细胞瘤
0.4%Leads under 1 in 100 of China's research papers on Neuroblastoma New since 2021

Led 4 of 1,132 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (8.8%).

Run this PubMed search

Open trials led
0
Research papers it led
4
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.09%
Papers led per year
2021: 0020212022: 2220222023: 0020232024: 2220242025: 002025

Hospitals counted here

  1. First Affiliated Hospital of Guangdong Pharmaceutical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Wilson disease

肝豆状核变性(Wilson 病)
3.0%Leads about 1 in 33 of China's research papers on Wilson disease ▼ from 5.2%

Led 6 of 201 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (7.5%).

Run this PubMed search

Open trials led
0
Research papers it led
6
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.9%
Papers led per year
2021: 1120212022: 2220222023: 1120232024: 0020242025: 112025
ThemesGenetics (ATP7B)Treatment (chelation, zinc)Liver disease & transplant

Hospitals counted here

  1. First Affiliated Hospital of Guangdong Pharmaceutical University3
  2. First Affiliated Hospital of School of Clinical Medicine of Guangdong Pharmaceutical University1
  3. First Affiliated Hospital of Clinical Medicine College of Guangdong Pharmaceutical University1
  4. first affiliated hospital, School of Clinical Medicine of Guangdong Pharmaceutical University1

Papers led, 2021–2025. Provincial and city hospitals with teaching links are not grouped.

PubMed searchClinicalTrials.gov

Duchenne muscular dystrophy

杜氏肌营养不良
0.9%Leads under 1 in 100 of China's research papers on Duchenne muscular dystrophy

Led 2 of 213 English-language PubMed papers from mainland China, 2021–2025 (first or last author lists this institution first).

The bar compares it with the institution that has the largest share (10.8%).

Run this PubMed search

Open trials led
0
Research papers it led
2
Trials it led
0
Share of China's trials
0.0%
Share of the world's papers
0.08%
Papers led per year
2021: 1120212022: 1120222023: 0020232024: 0020242025: 002025

PubMed searchClinicalTrials.gov